Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
XerostomiaDiabetes Mellitus
Interventions
OTHER

Diode Laser 980 nm, 0.2W

diode laser will be used at an operating wavelength of 980 nm, with adoption of the due safety measures in all cases. Laser irradiation will be applied bilaterally to the skin over the area of the submandibular and parotid glands. Irradiation will be applied externally to the parotid gland on a continuous basis and likewise to the submandibular gland moving the laser very slowly over the gland zone

OTHER

Placebo Diode laser

the tip of the instrument will be sealed with blue rubber to prevent the passage of light

Trial Locations (1)

Unknown

Outpatient Clinic of Oral medicine Department, Faculty of Dentistry, Alexandria University, Egypt, Alexandria

All Listed Sponsors
lead

Hams Hamed Abdelrahman

OTHER